Odyssey Therapeutics (NASDAQ:ODTX) Announces Quarterly Earnings Results

Odyssey Therapeutics (NASDAQ:ODTX) announced its quarterly earnings data on Wednesday. The company reported $999.00 earnings per share (EPS) for the quarter, Zacks reports.

Odyssey Therapeutics Trading Up 3.4%

Shares of NASDAQ:ODTX traded up $0.61 on Wednesday, reaching $18.48. 471,191 shares of the company traded hands, compared to its average volume of 324,281. Odyssey Therapeutics has a fifty-two week low of $15.35 and a fifty-two week high of $20.30.

Analysts Set New Price Targets

ODTX has been the topic of a number of research reports. Oppenheimer initiated coverage on Odyssey Therapeutics in a research report on Tuesday, June 2nd. They set an “outperform” rating and a $40.00 price target on the stock. Cantor Fitzgerald initiated coverage on Odyssey Therapeutics in a research report on Tuesday, June 2nd. They set an “overweight” rating on the stock. Zacks Research upgraded Odyssey Therapeutics to a “hold” rating in a research report on Wednesday, June 3rd. Wall Street Zen upgraded Odyssey Therapeutics to a “hold” rating in a research report on Saturday, May 16th. Finally, Wedbush initiated coverage on Odyssey Therapeutics in a research report on Tuesday, June 2nd. They set an “outperform” rating and a $30.00 price target on the stock. Five research analysts have rated the stock with a Buy rating and one has given a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $32.00.

Insider Activity at Odyssey Therapeutics

In related news, major shareholder Tpg Gp A, Llc acquired 1,388,889 shares of the business’s stock in a transaction dated Monday, May 11th. The stock was bought at an average price of $18.00 per share, for a total transaction of $25,000,002.00. Following the transaction, the insider owned 3,690,146 shares of the company’s stock, valued at approximately $66,422,628. The trade was a 60.35% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, major shareholder Sr One Capital Management, Llc sold 1,780 shares of the stock in a transaction on Monday, May 11th. The shares were sold at an average price of $18.00, for a total value of $32,040.00. Following the sale, the insider owned 440,981 shares of the company’s stock, valued at $7,937,658. This trade represents a 0.40% decrease in their position. The disclosure for this sale is available in the SEC filing. In the last three months, insiders have acquired 4,183,777 shares of company stock worth $75,319,986.